Terms: = Bone cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1
377 results:
1. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
2. Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.
Streuer A; Jann JC; Boch T; Mossner M; Riabov V; Schmitt N; Altrock E; Xu Q; Demmerle M; Nowak V; Oblaender J; Palme I; Weimer N; Rapp F; Metzgeroth G; Hecht A; Höger T; Merz C; Hofmann WK; Nolte F; Nowak D
Ann Hematol; 2024 Apr; 103(4):1221-1233. PubMed ID: 38413410
[TBL] [Abstract] [Full Text] [Related]
3. Cytogenetic, Clinical, Hematologic, Demographic, Immunohistochemical, and Flow Cytometry Characteristics of Patients with Plasma Cell Neoplasm in Five Years: A First Report from Iran.
Shokripour M; Hosseini SE; Omidifar N; Mokhtari M; Safaei A
Iran J Med Sci; 2024 Feb; 49(2):77-87. PubMed ID: 38356489
[TBL] [Abstract] [Full Text] [Related]
4. Quality control of postoperative radiotherapy for non-small cell lung cancer: A study of mediastinal shift.
Zhang W; Zhang Y; Ouyang WW; Fa Su S; Ma Z; Li QS; Gang Yang W; Xia Chen X; Liu J; Lu B
Cancer Radiother; 2024 Apr; 28(2):152-158. PubMed ID: 38320903
[TBL] [Abstract] [Full Text] [Related]
5. The crosstalk of CD8+ T cells and ferroptosis in cancer.
Lin Z; Zou S; Wen K
Front Immunol; 2023; 14():1255443. PubMed ID: 38288118
[TBL] [Abstract] [Full Text] [Related]
6. The Apoptotic Property of Nymphaea Caerulea Flower Extract on Acute Myeloid Leukaemia Cell Line, THP-1.
Chatterjee D; Singh B; Paira K; Das S
Asian Pac J Cancer Prev; 2024 Jan; 25(1):123-137. PubMed ID: 38285776
[TBL] [Abstract] [Full Text] [Related]
7. Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models.
Hu J; Lazar AJ; Ingram D; Wang WL; Zhang W; Jia Z; Ragoonanan D; Wang J; Xia X; Mahadeo K; Gorlick R; Li S
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199607
[TBL] [Abstract] [Full Text] [Related]
8. Long-Term Outcomes of Infantile Sacrococcygeal Teratoma: Results from a Multi-Institutional Retrospective Observational Study in Japan.
Fumino S; Hirohata Y; Takayama S; Tajiri T; Usui N; Taguchi T;
J Pediatr Surg; 2024 Apr; 59(4):587-592. PubMed ID: 38158258
[TBL] [Abstract] [Full Text] [Related]
9. Application of thromboelastography to predict the severity of bleeding after chimeric antigen receptor (CAR)-T cell therapy in patients with hematological malignancy.
Chen L; Ding S; Cheng Y; Zhou L; Yan J; Cheng Q; Jin A; Zhou X; Huang H; Hu Y
Eur J Haematol; 2024 Feb; 112(2):257-265. PubMed ID: 37698159
[TBL] [Abstract] [Full Text] [Related]
10. Distinct mechanisms of PTEN inactivation in dogs and humans highlight convergent molecular events that drive cell division in the pathogenesis of osteosarcoma.
Sarver AL; Mills LJ; Makielski KM; Temiz NA; Wang J; Spector LG; Subramanian S; Modiano JF
Cancer Genet; 2023 Aug; 276-277():1-11. PubMed ID: 37267683
[TBL] [Abstract] [Full Text] [Related]
11. More help than harm: surgery for metastatic spinal cord compression is associated with more favorable overall survival within a propensity score analysis.
Leitner L; Bratschitsch G; Kostwein A; Sadoghi P; Smolle M; Leithner A; Posch F
Eur Spine J; 2023 Jul; 32(7):2468-2478. PubMed ID: 37178222
[TBL] [Abstract] [Full Text] [Related]
12. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the bone Marrow Pathology Group.
Cantu MD; Kanagal-Shamanna R; Wang SA; Kadia T; Bueso-Ramos CE; Patel SS; Geyer JT; Tam W; Madanat Y; Li P; George TI; Nichols MM; Rogers HJ; Liu YC; Aggarwal N; Kurzer JH; Maracaja DLV; Hsi ED; Zaiem F; Babu D; Foucar K; Laczko D; Bagg A; Orazi A; Arber DA; Hasserjian RP; Weinberg OK
JCO Precis Oncol; 2023 Jan; 7():e2200400. PubMed ID: 36689697
[TBL] [Abstract] [Full Text] [Related]
14. Establishment and Validation of a Machine Learning Prediction Model Based on Big Data for Predicting the Risk of bone Metastasis in Renal Cell Carcinoma Patients.
Xu C; Liu W; Yin C; Li W; Liu J; Sheng W; Tang H; Li W; Zhang Q
Comput Math Methods Med; 2022; 2022():5676570. PubMed ID: 36226243
[TBL] [Abstract] [Full Text] [Related]
15. Radiotherapy activity in the COVID 19 pandemic: Brazil's operational national-level study.
Moraes FY; Gouveia AG; Lima RP; Bratti VF; Hamamura AC; Viani GA
J Cancer Policy; 2023 Jun; 36():100367. PubMed ID: 36216270
[TBL] [Abstract] [Full Text] [Related]
16. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry.
Müller V; Hein A; Hartkopf AD; Fasching PA; Kolberg HC; Hadji P; Tesch H; Häberle L; Ettl J; Lüftner D; Wallwiener M; Beckmann MW; Schneeweiss A; Belleville E; Uhrig S; Wimberger P; Hielscher C; Meyer J; Wurmthaler LA; Kurbacher CM; Wuerstlein R; Untch M; Janni W; Taran FA; Lux MP; Wallwiener D; Brucker SY; Fehm TN; Michel LL
Eur J Cancer; 2022 Sep; 172():13-21. PubMed ID: 35728342
[TBL] [Abstract] [Full Text] [Related]
17. Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.
Beelen DW; Stelljes M; Reményi P; Wagner-Drouet EM; Dreger P; Bethge W; Ciceri F; Stölzel F; Junghanß C; Labussiere-Wallet H; Schaefer-Eckart K; Grigoleit GU; Scheid C; Patriarca F; Rambaldi A; Niederwieser D; Hilgendorf I; Russo D; Socié G; Holler E; Glass B; Casper J; Wulf G; Basara N; Bieniaszewska M; Stuhler G; Verbeek M; La Rocca U; Finke J; Benedetti F; Pichlmeier U; Klein A; Baumgart J; Markiewicz M
Am J Hematol; 2022 Aug; 97(8):1023-1034. PubMed ID: 35617104
[TBL] [Abstract] [Full Text] [Related]
18. Dose-efficient assessment of trabecular microstructure using ultra-high-resolution photon-counting CT.
Peña JA; Klein L; Maier J; Damm T; Schlemmer HP; Engelke K; Glüer CC; Kachelrieß M; Sawall S
Z Med Phys; 2022 Nov; 32(4):403-416. PubMed ID: 35597742
[TBL] [Abstract] [Full Text] [Related]
19. Fatty acids derived from apoptotic chondrocytes fuel macrophages FAO through MSR1 for facilitating BMSCs osteogenic differentiation.
Zheng ZY; Jiang T; Huang ZF; Chu B; Gu J; Zhao X; Liu H; Fan J; Yu LP; Jiang SH; Li Q; Hu LP; Kong FQ; Zhang L; Chen Q; Chen J; Zhang HW; Yin GY; Zhao SJ
Redox Biol; 2022 Jul; 53():102326. PubMed ID: 35525025
[TBL] [Abstract] [Full Text] [Related]
20. Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy.
Maitre E; Cornet E; Debliquis A; Drenou B; Gravey F; Chollet D; Cheze S; Docquier M; Troussard X; Matthes T
J Cancer Res Clin Oncol; 2022 Aug; 148(8):2013-2022. PubMed ID: 35476232
[TBL] [Abstract] [Full Text] [Related]
[Next]
